FindTrial
Sign In

Comparative evaluation of implant longevity among two groups in low vitamin D3 Patients

Comparative evaluation of implant stability in low vitamin D3 patients with and without vitamin D3 supplementation A randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074422
Enrollment
34
Registered
2024-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z048- Encounter for examination and observation for other specified reasons

Interventions

Intervention1: VITAMIN D3[WELL B D3] Cholecalciferol: VITAMIN D3[WELL B D3] Cholecalciferol chewable tablets 60,000 I.U.given by oral route once in a week mfg by BELIEVEWELLNESS INTERNATIONAL LIMITED

Sponsors

Dr Mukesh shivaji patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with posterior edentulous spaces having D2 and D3 bone quality. 2. Patients within the age group of 20–45 years of either gender. 3. Individuals with good systemic health with no known contraindication for surgery. 4. Presence of adequate bone volume to accommodate an implant of appropriate size all around the implant . 5.All patients with vitamin D level below 30ng/ml.

Exclusion criteria

Exclusion criteria: 1. If there was any anterior edentulous spaces present. 2. If the edentulous sites had any signs of acute infection. 3. If the patient had a medical history that would compromise the treatment outcome. 4. Patients with parafunctional habits and temporal mandibular joint disorders 5. Pregnant or lactating women. 6. Chronic smokers and alcoholics . 7. Patients allergic to any medicines which are likely to be used during the treatment period.

Design outcomes

Primary

MeasureTime frame
To compare and evaluate the relationship between implant stability and vitamin D3 level with and without vitamin D3 supplementation by using resonance frequency analyzer (osstell-ISQ) .Timepoint: 12 week—

Secondary

MeasureTime frame
1.To evaluate implant stability quotient (ISQ) - at the time of implant placement. 2.To evaluate implant stability quotient after vitamin D3 supplementation . 3.To compare and evaluate relation between implant stability and vitamin D3 level at the time of implant placement . 4.To compare and evaluate implant stability with vitamin D3 levels after vitamin D3 supplementation.Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactDR Abhay Narayane

DR.HSRSM DENTAL COLLEGE AND HOSPITAL,HINGOLI

abhay.narayane16@gmail.com9960973901

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026